Trial Profile
A prospective, observational study of Insulin Glargine 100 U/mL in patients with Type 2 Diabetes poorly controlled on oral antidiabetic drugs
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jun 2020
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms TOP-1
- 08 Dec 2017 Results (n=2308) presented at the 2017 Congress of the International Diabetes Federation
- 15 Sep 2017 Results (n=2308) presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
- 17 Jul 2017 New trial record